Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.
Dig Dis. 2022;40(6):826-834. doi: 10.1159/000522121. Epub 2022 Jan 24.
Use of risk scores for early assessment of patients with upper gastrointestinal bleeding (UGIB) is recommended by various guidelines. We compared Cologne-WATCH (C-WATCH) score with Glasgow-Blatchford score (GBS), Rockall score (RS), and pre-endoscopic RS (p-RS).
Patients with UGIB between January and December 2017 were retrospectively analyzed for 30-day mortality and composite endpoints risk of complications and need for intervention using areas under the receiver-operating characteristics curve (AUROC). Subgroup analysis was conducted for patients with UGIB on admission and in-hospital UGIB.
A total of 252 patients were identified (67.5% men, mean age 63.8 ± 14.9 years). In-hospital UGIB occurred in 49.6%. AUROCs for 30-day mortality, risk of complications, and need for intervention (not applicable to RS) were 0.684 (95% confidence interval [CI]: 0.606-0.763), 0.665 (95% CI: 0.594-0.735), and 0.694 (95% CI: 0.612-0.775) for C-WATCH score, 0.724 (95% CI: 0.653-0.796) and 0.751 (95% CI: 0.687-0.815) for RS, 0.652 (95% CI: 0.57-0.735), 0.653 (95% CI: 0.579-0.727), and 0.673 (95% CI: 0.602-0.745) for p-RS and 0.652 (95% CI: 0.572-0.732), 0.663 (95% CI: 0.592-0.734), and 0.752 (95% CI: 0.683-0.821) for GBS. RS outperformed pre-endoscopic scores in predicting risk of complications, while there were no significant differences between pre-endoscopic scores except GBS outperforming p-RS in predicting need for intervention. The subgroup analysis obtained similar results. Positive predictive values for patients with estimated low risk for all three endpoints (C-WATCH score ≤1, RS ≤2, p-RS <1, and GBS ≤1) were 89%, 69%, 78%, and 92%.
C-WATCH score performed similar to the established pre-endoscopic risk scores in patients with UGIB regarding relevant patient-related endpoints with no significant differences between both the subgroups.
各种指南都推荐使用风险评分来早期评估上消化道出血(UGIB)患者。我们比较了科隆观察(C-WATCH)评分与格拉斯哥-布拉奇福德评分(GBS)、罗克厄尔评分(RS)和内镜前 RS(p-RS)。
回顾性分析 2017 年 1 月至 12 月间 UGIB 患者的 30 天死亡率和复合终点(并发症风险和干预需求)的风险,采用受试者工作特征曲线下面积(AUROC)进行评估。对内出血入院患者和院内 UGIB 患者进行亚组分析。
共纳入 252 例患者(67.5%为男性,平均年龄 63.8±14.9 岁)。院内 UGIB 发生率为 49.6%。C-WATCH 评分的 30 天死亡率、并发症风险和干预需求(不适用于 RS)的 AUROC 分别为 0.684(95%置信区间 [CI]:0.606-0.763)、0.665(95% CI:0.594-0.735)和 0.694(95% CI:0.612-0.775),RS 评分的 AUROC 分别为 0.724(95% CI:0.653-0.796)和 0.751(95% CI:0.687-0.815),p-RS 评分的 AUROC 分别为 0.652(95% CI:0.57-0.735)、0.653(95% CI:0.579-0.727)和 0.673(95% CI:0.602-0.745),GBS 评分的 AUROC 分别为 0.652(95% CI:0.572-0.732)、0.663(95% CI:0.592-0.734)和 0.752(95% CI:0.683-0.821)。RS 在预测并发症风险方面优于内镜前评分,而内镜前评分之间除 GBS 在预测干预需求方面优于 p-RS 外,无显著差异。亚组分析得出了相似的结果。对于所有三个终点(C-WATCH 评分≤1、RS≤2、p-RS<1 和 GBS≤1)的估计低风险患者,阳性预测值分别为 89%、69%、78%和 92%。
在 UGIB 患者相关患者相关终点方面,C-WATCH 评分与既定的内镜前风险评分表现相似,两组之间无显著差异。